Alcresta Therapeutics Announces FDA Clearance for the Next-Generation RELiZORB® Digestive Enzyme Cartridge
/PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today...
Source: prnewswire.com